Literature DB >> 23234635

Differing perceptions of quality of life in patients with prostate cancer and their doctors.

Geoffrey A Sonn1, Natalia Sadetsky, Joseph C Presti, Mark S Litwin.   

Abstract

PURPOSE: As the number of prostate cancer survivors increases, urologists must recognize their quality of life impairment. In the past physician ratings of patient symptoms did not correlate with patient self-assessments. We determined if urologists have improved their reporting of patient health related quality of life. We also investigated if urologists assessed health related quality of life more accurately in the short or long term.
MATERIALS AND METHODS: We identified 1,366 men from CaPSURE™, a national, prospective cohort, who had undergone prostatectomy, brachytherapy or external beam radiation therapy. At each visit urologists assessed fatigue, pain, and sexual, urinary and bowel dysfunction. Participants independently completed the SF-36™ and the UCLA-PCI. We contrasted the frequency of impairment reported by physicians and participants in select health related quality of life domains in the short (less than 1 year) and long (greater than 2 years) term. We also compared physician-patient concordance between the periods 1995 to 2000 and 2001 to 2007.
RESULTS: In short-term and long-term followup, and for the 1995 to 2000 and 2001 to 2007 cohorts, physician and participant assessments differed in all analyzed domains. Urologists noted impairment in urinary and sexual function more often than fatigue or pain. Disagreement between physician and participant ratings did not vary dramatically from short-term to long-term followup, or from the earlier to the later cohort.
CONCLUSIONS: In men treated for localized prostate cancer physician ratings of symptoms do not correlate well with patient self-assessments of health related quality of life. Physician reporting did not improve over time. It is increasingly important to recognize and address impairments in quality of life from prostate cancer and its treatment.
Copyright © 2013 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23234635     DOI: 10.1016/j.juro.2012.11.032

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  26 in total

1.  Physical and emotional health information needs and preferences of long-term prostate cancer survivors.

Authors:  Eric S Zhou; Sharon L Bober; Larissa Nekhlyudov; Jim C Hu; Philip W Kantoff; Christopher J Recklitis
Journal:  Patient Educ Couns       Date:  2016-07-14

Review 2.  Patient-reported outcomes and survivorship in radiation oncology: overcoming the cons.

Authors:  Farzan Siddiqui; Arthur K Liu; Deborah Watkins-Bruner; Benjamin Movsas
Journal:  J Clin Oncol       Date:  2014-08-11       Impact factor: 44.544

3.  Measuring and predicting prostate cancer related quality of life changes using EPIC for clinical practice.

Authors:  Jonathan J Chipman; Martin G Sanda; Rodney L Dunn; John T Wei; Mark S Litwin; Catrina M Crociani; Meredith M Regan; Peter Chang
Journal:  J Urol       Date:  2013-09-25       Impact factor: 7.450

4.  Transitions in Symptom Cluster Subgroups Among Men Undergoing Prostate Cancer Radiation Therapy.

Authors:  Shannon Ruff Dirksen; Michael J Belyea; William Wong; Dana R Epstein
Journal:  Cancer Nurs       Date:  2016 Jan-Feb       Impact factor: 2.592

Review 5.  Promise of Wearable Physical Activity Monitors in Oncology Practice.

Authors:  Muhammad S Beg; Arjun Gupta; Tyler Stewart; Chad D Rethorst
Journal:  J Oncol Pract       Date:  2017-02       Impact factor: 3.840

6.  Surgical quality is more than volume: the association between changing urologists and complications for patients with localized prostate cancer.

Authors:  Eva H DuGoff; Justin E Bekelman; Elizabeth A Stuart; Katrina Armstrong; Craig Evan Pollack
Journal:  Health Serv Res       Date:  2014-01-24       Impact factor: 3.402

7.  Quality-of-life assessment after palliative interventions to manage malignant ureteral obstruction.

Authors:  Wayne Laurence Monsky; Chris Molloy; Bedro Jin; Timothy Nolan; Dayantha Fernando; Shaun Loh; Chin-Shang Li
Journal:  Cardiovasc Intervent Radiol       Date:  2013-02-13       Impact factor: 2.740

8.  The association of long-term treatment-related side effects with cancer-specific and general quality of life among prostate cancer survivors.

Authors:  Kimberly M Davis; Scott P Kelly; George Luta; Catherine Tomko; Anthony B Miller; Kathryn L Taylor
Journal:  Urology       Date:  2014-06-26       Impact factor: 2.649

9.  Feasibility, acceptability, and preliminary efficacy of a technology-assisted psychosocial intervention for racially diverse men with advanced prostate cancer.

Authors:  Betina Yanez; Heather L McGinty; David C Mohr; Mark J Begale; Jason R Dahn; Sarah C Flury; Kent T Perry; Frank J Penedo
Journal:  Cancer       Date:  2015-09-08       Impact factor: 6.860

10.  Patient-Reported Functional Outcomes After Hypofractionated or Conventionally Fractionated Radiation for Prostate Cancer: A National Cohort Study in England.

Authors:  Julie Nossiter; Arunan Sujenthiran; Thomas E Cowling; Matthew G Parry; Susan C Charman; Paul Cathcart; Noel W Clarke; Heather Payne; Jan van der Meulen; Ajay Aggarwal
Journal:  J Clin Oncol       Date:  2020-01-02       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.